New combo treatment for vitiligo shows promise in early trial
NCT ID NCT07563049
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether injecting carbon dioxide gas (carboxytherapy) alongside standard narrowband UVB light therapy can improve repigmentation in people with stable vitiligo. Fifty-nine participants with symmetrical patches will receive whole-body UVB light, with carboxytherapy added on one side only. The study measures changes in skin color and certain blood markers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- carbon dioxide gas
- What this could lead to
- If it works, this could offer a better way to restore skin color in people with stable vitiligo.
- What could go wrong
- This is a small, early-phase trial with only 59 people. The added benefit of carboxytherapy may be small or none, and injections can cause discomfort or bruising.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO VULGARIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine, Cairo University
Cairo, El Manial, 11956, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.